Antimicrobial Susceptibility StudiesSynergy of Polymyxin B (cas 1404-26-8), tigecycline and meropenem against carbapenem-resistant Enterobacter cloacae complex isolates
-
Add time:09/08/2019 Source:sciencedirect.com
Here, we evaluated the combinations of antibiotics polymyxin B (PMB), tigecycline (TGC) and meropenem (MEM) by time-kill curves (TKC) against carbapenem-resistant Enterobacter cloacae isolates. Combination of PMB/TGC and PMB/MEM showed promising results in sub-inhibitory concentration of PMB indicating the possibility of reducing the dose of PMB used in the treatment.
We also recommend Trading Suppliers and Manufacturers of Polymyxin B (cas 1404-26-8). Pls Click Website Link as below: cas 1404-26-8 suppliers
Prev:Combination therapy with Polymyxin B (cas 1404-26-8) for carbapenemase-producing Klebsiella pneumoniae bloodstream infection
Next:Antimicrobial Susceptibility StudyStaggering the administration of Polymyxin B (cas 1404-26-8) and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Brief communicationEarly use of Polymyxin B (cas 1404-26-8) reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection09/10/2019
- Antimicrobial Susceptibility StudyStaggering the administration of Polymyxin B (cas 1404-26-8) and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs09/09/2019
- Combination therapy with Polymyxin B (cas 1404-26-8) for carbapenemase-producing Klebsiella pneumoniae bloodstream infection09/07/2019
- An alternative strategy for combination therapy: Interactions between Polymyxin B (cas 1404-26-8) and non-antibiotics09/06/2019
- Original articlePolymyxin B (cas 1404-26-8) Etest® compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of Polymyxin B (cas 1404-26-8) MICs09/05/2019
- Comparison of the composition and in vitro activity of Polymyxin B (cas 1404-26-8) products09/04/2019
- Co-delivery of buparvaquone and Polymyxin B (cas 1404-26-8) in nanostructured lipid carrier for leishmaniasis treatment09/03/2019
- BacteriologyBiofilm prevention concentrations (BPC) of minocycline compared to Polymyxin B (cas 1404-26-8), meropenem, and amikacin against Acinetobacter baumannii09/02/2019
- Polymyxin B (cas 1404-26-8) and polymyxin E induce anaphylactoid response through mediation of Mas-related G protein–coupled receptor X209/01/2019
-
Health and Chemical more >